Literature DB >> 3417870

Plasma clearance of human extracellular-superoxide dismutase C in rabbits.

K Karlsson1, S L Marklund.   

Abstract

Extracellular-superoxide dismutase (EC-SOD) is heterogenous in the vasculature with regard to heparin affinity and can be separated into three fractions: A, without affinity; B, with weak affinity; and C, with relatively strong heparin affinity. The plasma clearance of intravenously injected 125I-labeled and unlabeled human EC-SOD C was studied in rabbits. About 90% of injected 125I-EC-SOD C was eliminated from the blood within 5-10 min. Injection of heparin after 10 or 20 min led to an immediate release of all sequestered 125I-EC-SOD C back to the blood plasma. Later injections of heparin led to diminished release, although release could still be demonstrated after 72 h. A half-time of approximately 10 h could be calculated for heparin-releasable 125I-EC-SOD C. Unlabeled EC-SOD C, determined as enzymic activity and with ELISA, was likewise sequestered and released to the same degree as 125I-labeled EC-SOD C by heparin as tested at 20 min and 5 h. The immediacy of the heparin-induced release indicates that the sequestered enzyme had been bound to endothelial cell surfaces. The length of the half-time suggests that the putative cell surface binding has a physiological function and is not primarily a step in enzyme degradation. The distribution of sequestered 125I-labeled EC-SOD C to different organs was determined at times between 10 min and 24 h. Of the organs, the liver contained the most 125I-EC-SOD C, followed by kidney, spleen, heart, and lung. At all investigated times, the content in the analyzed organs was nearly as large as the amount that could be promptly released to plasma by intravenous heparin. This indicates that almost all 125I-EC-SOD C in the organs was present on endothelial cell surfaces and was not bound by other tissue cell surfaces, or was present within the cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3417870      PMCID: PMC303580          DOI: 10.1172/JCI113676

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

1.  Spectrophotometric study of spontaneous disproportionation of superoxide anion radical and sensitive direct assay for superoxide dismutase.

Authors:  S Marklund
Journal:  J Biol Chem       Date:  1976-12-10       Impact factor: 5.157

2.  Properties of extracellular superoxide dismutase from human lung.

Authors:  S L Marklund
Journal:  Biochem J       Date:  1984-05-15       Impact factor: 3.857

Review 3.  Cell-surface glycosaminoglycans.

Authors:  M Höök; L Kjellén; S Johansson
Journal:  Annu Rev Biochem       Date:  1984       Impact factor: 23.643

4.  Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenyl glycoluril (Iodogen).

Authors:  P R Salacinski; C McLean; J E Sykes; V V Clement-Jones; P J Lowry
Journal:  Anal Biochem       Date:  1981-10       Impact factor: 3.365

5.  Binding of platelet factor 4 to cultured human umbilical vein endothelial cells.

Authors:  C Busch; J Dawes; D S Pepper; A Wasteson
Journal:  Thromb Res       Date:  1980 Jul 1-15       Impact factor: 3.944

6.  A simple specific method for the determination of the hemoglobin content of tissue homogenates.

Authors:  S Marklund
Journal:  Clin Chim Acta       Date:  1979-03-01       Impact factor: 3.786

7.  Rapid removal to the liver of intravenously injected lipoprotein lipase.

Authors:  L Wallinder; G Bengtsson; T Olivecrona
Journal:  Biochim Biophys Acta       Date:  1979-10-26

8.  Superoxide dismutase in extracellular fluids.

Authors:  S L Marklund; E Holme; L Hellner
Journal:  Clin Chim Acta       Date:  1982-11-24       Impact factor: 3.786

9.  Human copper-containing superoxide dismutase of high molecular weight.

Authors:  S L Marklund
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

10.  Hepatic and extrahepatic uptake of intravenously injected lipoprotein lipase.

Authors:  L Wallinder; J Peterson; T Olivecrona; G Bengtsson-Olivecrona
Journal:  Biochim Biophys Acta       Date:  1984-10-04
View more
  17 in total

1.  Large-plaque mutants of Sindbis virus show reduced binding to heparan sulfate, heightened viremia, and slower clearance from the circulation.

Authors:  A P Byrnes; D E Griffin
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Long-term hyperglycaemia decreases vascular fraction of extracellular superoxide dismutase.

Authors:  K Ciechanowski; K Kedzierska; E Herdzik; J Bober; L Domański; K Borowiak; J Rózański; M Myślak
Journal:  Diabetologia       Date:  2003-06-27       Impact factor: 10.122

3.  A non-glycosylated extracellular superoxide dismutase variant.

Authors:  A Edlund; T Edlund; K Hjalmarsson; S L Marklund; J Sandström; M Strömqvist; L Tibell
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

4.  Expression of extracellular superoxide dismutase by human cell lines.

Authors:  S L Marklund
Journal:  Biochem J       Date:  1990-02-15       Impact factor: 3.857

5.  Binding of Sindbis virus to cell surface heparan sulfate.

Authors:  A P Byrnes; D E Griffin
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

6.  Detection of glycosaminoglycans on the surface of human umbilical vein endothelial cells using gold-conjugated poly-L-lysine with silver enhancement.

Authors:  N J Klein; G I Shennan; R S Heyderman; M Levin
Journal:  Histochem J       Date:  1993-04

7.  The rat extracellular superoxide dismutase dimer is converted to a tetramer by the exchange of a single amino acid.

Authors:  L M Carlsson; S L Marklund; T Edlund
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

8.  Non-enzymic glycation of human extracellular superoxide dismutase.

Authors:  T Adachi; H Ohta; K Hirano; K Hayashi; S L Marklund
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

9.  Proteolytic modification of the heparin-binding affinity of extracellular superoxide dismutase.

Authors:  K Karlsson; A Edlund; J Sandström; S L Marklund
Journal:  Biochem J       Date:  1993-03-01       Impact factor: 3.857

10.  Substitution of glycine for arginine-213 in extracellular-superoxide dismutase impairs affinity for heparin and endothelial cell surface.

Authors:  T Adachi; H Yamada; Y Yamada; N Morihara; N Yamazaki; T Murakami; A Futenma; K Kato; K Hirano
Journal:  Biochem J       Date:  1996-01-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.